Drug Type Small molecule drug |
Synonyms YK 1002 |
Target |
Action stimulants |
Mechanism VISTA stimulants(V-domain Ig suppressor of T-cell activation stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | China | 20 Sep 2022 | |
Melanoma | Preclinical | China | 20 Sep 2022 | |
Stomach Cancer | Preclinical | China | 20 Sep 2022 |